Compare UCL & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UCL | BNGO |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 12.5M |
| IPO Year | 2019 | 2018 |
| Metric | UCL | BNGO |
|---|---|---|
| Price | $0.22 | $1.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 136.5K | ★ 171.3K |
| Earning Date | 11-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | N/A | $13.91 |
| Revenue Next Year | $15.99 | $33.34 |
| P/E Ratio | $13.72 | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.19 | $1.00 |
| 52 Week High | $2.63 | $2.23 |
| Indicator | UCL | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 35.93 |
| Support Level | N/A | $1.08 |
| Resistance Level | $0.44 | $1.19 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 53.49 | 19.97 |
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.